Altimmune Inc (NASDAQ:ALT) shares, rose in value, with the stock price up by 1.69% to the previous day’s close as strong demand from buyers drove the stock to $7.20.
Actively observing the price movement in the last trading, the stock closed the session at $7.08. Referring to stock’s 52-week performance, its high was $14.84, and the low was $2.09. On the whole, ALT has fluctuated by -16.76% over the past month.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ALT’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of ALT currently trading nearly -12.93% and -22.75% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 38.71, while the 7-day volatility ratio is showing 8.79% which for the 30-day chart, stands at 9.01%. Furthermore, Altimmune Inc (ALT)’s beta value is 0.17, and its average true range (ATR) is 0.72.
A comparison of Altimmune Inc (ALT) with its peers suggests the former has fared considerably weaker in the market. ALT showed an intraday change of 1.69% in last session, and over the past year, it grew by 37.67%%.
Data on historical trading for Altimmune Inc (NASDAQ:ALT) indicates that the trading volumes over the past 3 months, they’ve averaged 4.68 million. According to company’s latest data on outstanding shares, there are 70.68 million shares outstanding.
Nearly 1.02% of Altimmune Inc’s shares belong to company insiders and institutional investors own 62.16% of the company’s shares. The stock has fallen by -36.00% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ALT stock heading into the next quarter.
